PLoS ONE (Aug 2008)

Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.

  • Fadi Bittar,
  • Hervé Richet,
  • Jean-Christophe Dubus,
  • Martine Reynaud-Gaubert,
  • Nathalie Stremler,
  • Jacques Sarles,
  • Didier Raoult,
  • Jean-Marc Rolain

DOI
https://doi.org/10.1371/journal.pone.0002908
Journal volume & issue
Vol. 3, no. 8
p. e2908

Abstract

Read online

BackgroundThere is strong evidence that culture-based methods detect only a small proportion of bacteria present in the respiratory tracts of cystic fibrosis (CF) patients.Methodology/principal findingsStandard microbiological culture and phenotypic identification of bacteria in sputa from CF patients have been compared to molecular methods by the use of 16S rDNA amplification, cloning and sequencing. Twenty-five sputa from CF patients were cultured that yield 33 isolates (13 species) known to be pathogens during CF. For molecular cloning, 760 clones were sequenced (7.2+/-3.9 species/sputum), and 53 different bacterial species were identified including 16 species of anaerobes (30%). Discrepancies between culture and molecular data were numerous and demonstrate that accurate identification remains challenging. New or emerging bacteria not or rarely reported in CF patients were detected including Dolosigranulum pigrum, Dialister pneumosintes, and Inquilinus limosus.Conclusions/significanceOur results demonstrate the complex microbial community in sputa from CF patients, especially anaerobic bacteria that are probably an underestimated cause of CF lung pathology. Metagenomic analysis is urgently needed to better understand those complex communities in CF pulmonary infections.